Literature DB >> 17324749

Blood pressure parameters and risk of fatal stroke, NHANES II mortality study.

David W Brown1, Wayne H Giles, Kurt J Greenlund.   

Abstract

BACKGROUND: Recent studies have suggested that systolic blood pressure (BP) is a better predictor of stroke than diastolic BP in apparently healthy white men. Whether these relationships are similar for women and African Americans remains unclear.
METHODS: We used data from 6667 (3205 men; 3462 women) adults from the Second National Health and Nutrition Examination Survey Mortality Study to examine whether the relative risk of fatal stroke was associated with a 10 mm Hg increase in BP parameters (systolic BP, diastolic BP, pulse pressure, and mean arterial pressure).
RESULTS: During a median of nearly 15 years of follow-up, 113 fatal strokes (62 men; 51 women) occurred. Systolic BP was associated with an increased risk of fatal stroke for men (relative risk [RR] = 1.19), women (RR = 1.15), whites (RR = 1.17), and African Americans (RR = 1.28) after multivariable adjustment (all, P </= .05). Results for other BP parameters were not consistent; simultaneous consideration of two parameters did not improve prediction of fatal stroke over systolic BP alone.
CONCLUSIONS: Our results agree with previous studies that indicate systolic BP is an important predictor of stroke risk for all groups within the population and provide further evidence of the need to control systolic BP in the population.

Entities:  

Mesh:

Year:  2007        PMID: 17324749     DOI: 10.1016/j.amjhyper.2006.08.004

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  26 in total

1.  Is pulse pressure an independent risk factor for incident acute coronary heart disease events? The REGARDS study.

Authors:  Stephen P Glasser; Daniel L Halberg; Charlie Sands; Christopher M Gamboa; Paul Muntner; Monika Safford
Journal:  Am J Hypertens       Date:  2013-09-12       Impact factor: 2.689

2.  Hemorheological profiles of subjects with prehypertension.

Authors:  Cesare Tripolino; Agostino Gnasso; Claudio Carallo; Faustina Barbara Scavelli; Concetta Irace
Journal:  Hypertens Res       Date:  2016-02-25       Impact factor: 3.872

Review 3.  Coronary heart disease risk factors and outcomes in the twenty-first century: findings from the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study.

Authors:  Hemal Bhatt; Monika Safford; Stephen Glasser
Journal:  Curr Hypertens Rep       Date:  2015-04       Impact factor: 5.369

Review 4.  Prehypertension: Underlying pathology and therapeutic options.

Authors:  Sulayma Albarwani; Sultan Al-Siyabi; Musbah O Tanira
Journal:  World J Cardiol       Date:  2014-08-26

5.  Is Pulse Pressure an Independent Risk Factor for Incident Stroke, REasons for Geographic And Racial Differences in Stroke.

Authors:  Stephen P Glasser; Daniel L Halberg; Charles D Sands; Aleena Mosher; Paul M Muntner; George Howard
Journal:  Am J Hypertens       Date:  2015-01-14       Impact factor: 2.689

Review 6.  Blood pressure control versus atrial fibrillation management in stroke prevention.

Authors:  Carmine Savoia; Lidia Sada; Massimo Volpe
Journal:  Curr Hypertens Rep       Date:  2015-06       Impact factor: 5.369

Review 7.  Recent advances in understanding hypertension development in sub-Saharan Africa.

Authors:  A E Schutte; S Botha; C M T Fourie; L F Gafane-Matemane; R Kruger; L Lammertyn; L Malan; C M C Mels; R Schutte; W Smith; J M van Rooyen; L J Ware; H W Huisman
Journal:  J Hum Hypertens       Date:  2017-03-23       Impact factor: 3.012

8.  Gender and sex differences in job status and hypertension.

Authors:  Jane E Clougherty; Ellen A Eisen; Martin D Slade; Ichiro Kawachi; Mark R Cullen
Journal:  Occup Environ Med       Date:  2010-09-23       Impact factor: 4.402

9.  Cardiovascular risk in hypertension - can we ask for more? : focus on aliskiren.

Authors:  Massimo Volpe
Journal:  High Blood Press Cardiovasc Prev       Date:  2013-01-22

10.  Olmesartan medoxomil in elderly patients with essential or isolated systolic hypertension : efficacy and safety data from clinical trials.

Authors:  Anthony M Heagerty; Jean-Michel Mallion
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.